Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Shire plc | dp55613_8k.htm |
Exhibit 99.1
|
Press Release
|
 |
www.shire.com
Results of the 2015 Annual General Meeting
April 28, 2015 – Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces that at its Annual General Meeting held at The Merrion Hotel, Upper Merrion Street, Dublin 2, Ireland at 2.45pm today, all resolutions contained in the Notice of Meeting were decided by poll vote. The results of the poll are as follows:
|
Resolutions
|
For (including
discretionary
votes)
|
%
|
Against
|
%
|
Votes cast
as a % of
relevant
shares in
issue
|
Withheld
|
|
Ordinary Resolutions
|
||||||
|
1. To receive the Company’s Annual Report and Accounts for the year ended December 31, 2014.
|
438,413,528
|
99.13
|
3,865,083
|
0.87
|
74.76
|
1,417,850
|
|
2. To approve the Directors’ Remuneration Report.
|
429,855,512
|
97.20
|
12,372,754
|
2.80
|
74.75
|
1,468,195
|
|
3. To approve the Directors’ Remuneration Policy.
|
414,168,513
|
93.99
|
26,500,604
|
6.01
|
74.49
|
3,027,344
|
|
4. To elect Dominic Blakemore as a Director.
|
425,224,988
|
96.22
|
16,683,913
|
3.78
|
74.70
|
1,787,560
|
|
5. To re-elect William Burns as a Director.
|
440,687,897
|
99.64
|
1,573,615
|
0.36
|
74.75
|
1,434,949
|
|
6. To re-elect Dr. Steven Gillis as a Director.
|
438,960,079
|
99.25
|
3,300,979
|
0.75
|
74.75
|
1,435,403
|
|
7. To re-elect Dr. David Ginsburg as a Director.
|
442,090,768
|
99.96
|
170,504
|
0.04
|
74.75
|
1,435,189
|
|
8. To re-elect David Kappler as a Director.
|
433,823,989
|
98.25
|
7,732,861
|
1.75
|
74.64
|
2,139,611
|
|
9. To re-elect Susan Kilsby as a Director.
|
427,582,010
|
96.68
|
14,681,728
|
3.32
|
74.76
|
1,432,723
|
|
10. To re-elect Anne Minto as a Director.
|
429,569,604
|
97.15
|
12,580,758
|
2.85
|
74.74
|
1,546,099
|
|
11. To re-elect Dr. Flemming Ornskov as a Director.
|
442,091,049
|
99.96
|
174,121
|
0.04
|
74.76
|
1,431,291
|
|
12 .To re-appoint Deloitte LLP as the Company’s Auditor.
|
409,645,636
|
92.82
|
31,682,655
|
7.18
|
74.60
|
2,368,170
|
|
13. To authorize the Audit, Compliance & Risk Committee to determine the remuneration of the Auditor.
|
417,660,298
|
94.45
|
24,549,709
|
5.55
|
74.75
|
1,486,454
|
|
14. To approve the Shire Long Term Incentive Plan 2015.
|
395,422,460
|
90.35
|
42,216,836
|
9.65
|
73.97
|
6,057,165
|
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
|
15. To approve the Shire Global Employee Stock Purchase Plan.
|
437,887,308
|
99.22
|
3,427,952
|
0.78
|
74.59
|
2,381,201
|
|
16. To authorize the allotment of shares.
|
415,267,543
|
94.42
|
24,518,586
|
5.58
|
74.34
|
3,910,332
|
|
Special Resolutions
|
||||||
|
17. To authorize the disapplication of pre-emption rights.
|
424,987,901
|
96.89
|
13,648,641
|
3.11
|
74.14
|
5,059,919
|
|
18. To authorize purchases of own shares.
|
441,910,866
|
99.93
|
303,040
|
0.07
|
74.75
|
1,482,555
|
|
19. To approve the notice period for general meetings.
|
391,913,232
|
88.61
|
50,365,471
|
11.39
|
74.76
|
1,417,758
|
As at the record date, April 26, 2015, there were 591,616,476 ordinary shares in issue (excluding shares held in treasury). Shareholders are entitled to one vote per share. A vote “withheld” is not a vote in law and is not counted in the calculation of the proportion of votes validly cast.
In accordance with Listing Rule 9.6.2R copies of the relevant resolutions passed at the meeting have been submitted to the National Storage Mechanism and will be available for viewing shortly at: www.morningstar.co.uk/uk/nsm.
Tony Guthrie
Deputy Company Secretary
For further information please contact:
|
Investor Relations
|
||
|
Sarah Elton-Farr
|
seltonfarr@shire.com
|
+44 1256 894157
|
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.
www.shire.com